Algert Global’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-131,599
| Closed | -$291K | – | 1278 |
|
|
2025
Q1 | $291K | Sell |
131,599
-15,860
| -11% | -$35.1K | 0.01% | 1018 |
|
|
2024
Q4 | $804K | Buy |
147,459
+45,741
| +45% | +$249K | 0.02% | 831 |
|
|
2024
Q3 | $845K | Sell |
101,718
-49,160
| -33% | -$408K | 0.02% | 786 |
|
|
2024
Q2 | $1.08M | Buy |
+150,878
| New | +$1.08M | 0.04% | 665 |
|
|
2023
Q2 | – | Sell |
-47,113
| Closed | -$660K | – | 1191 |
|
|
2023
Q1 | $660K | Buy |
47,113
+2,999
| +7% | +$42K | 0.03% | 763 |
|
|
2022
Q4 | $631K | Sell |
44,114
-28,040
| -39% | -$401K | 0.04% | 733 |
|
|
2022
Q3 | $1.84M | Buy |
72,154
+8,651
| +14% | +$221K | 0.11% | 295 |
|
|
2022
Q2 | $1.8M | Buy |
63,503
+3,479
| +6% | +$98.8K | 0.14% | 226 |
|
|
2022
Q1 | $2.12M | Buy |
60,024
+30,479
| +103% | +$1.07M | 0.14% | 225 |
|
|
2021
Q4 | $1.24M | Buy |
29,545
+21,155
| +252% | +$886K | 0.15% | 216 |
|
|
2021
Q3 | $412K | Buy |
+8,390
| New | +$412K | 0.05% | 621 |
|